NovaUCD, the Innovation and Technology Transfer Centre at UCD, has appointed Dr Cormac Kilty to its board. Kilty is chairman of the Irish BioIndustry Association and founder and CEO of Irish biotechnology company Biotrin Holdings and chairman of the start-up company Opsona Therapeutics. Biotrin is one of Ireland’s leading biotechnology companies specialising in the development, manufacture and sale of diagnostic tests for the detection of new viruses and novel biomakers of organ damage. The NovaUCD Board advises UCD on the commercialisation of research and comprises senior representatives of industry, the public sector and the university.
